Chinese
Japan
English
ProBio Signs MOU to Form Strategic Partnership with GeneCraft To Development and Production of New AAV gene therapies - ProBio
ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program - ProBio
ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs - ProBio
ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies - ProBio
ProBio and ProteoNic BV Signed a Strategic Cooperation Based on High Expressing Vector System - ProBio
Athenex Partners with Leading Contract Manufacturer ProBio in the Development of Advanced Cell and Gene Therapies - ProBio
ProBio Signs CDMO Supply Agreement And Forms Strategic Partnership with AffyXell Therapeutics – A Joint Daewong-Avacta Venture- ProBio
National Cancer Center Japan and ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development - ProBio
ProBio initiates an Antibody CDMO contract for next-generation CD47 antibody with InnoBation Bio - ProBio
Successful Groundbreaking Ceremony for ProBio to Expand Commercial cGMP Plasmid and Viral Vector Manufacturing Facility in Zhenjiang, China - ProBio
ProBio and AbTis Enter into an Exclusive Worldwide License Agreement for ADC Targeting Claudin 18.2 - ProBio
China’s Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, ProBio Expanding Manufacturing Capacity Again - ProBio
ProBio Named a Top 10 Drug Discovery Solution Provider in Asia-Pacific - ProBio
ProBio Passed European Union Qualified Person (QP) Audit Successfully - ProBio
ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea - ProBio
ProBio and TG ImmunoPharma Enter into Collaboration on Innovative Antibody Drug Project - ProBio
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement
ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII - ProBio
ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme - ProBio
SunRock Biopharma and ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody Program